# Unilever plc: Form 20-F for the period ended Dec 31, 2021

- Company: [Unilever plc](/companies/ul.md) (CIK 217410)
- Form: 20-F
- Filed: 2022-03-09
- Accepted by EDGAR: Mar 9, 2022, 10:56 ET
- Period: 2021-12-31
- Accession: 0000217410-22-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/217410/000021741022000009/ul-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/217410/000021741022000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | EUR 52.44bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | EUR 30.26bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | EUR 22.18bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | EUR 8.70bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | EUR 1.94bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | EUR 6.05bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | EUR 2.32 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | EUR 2.33 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | EUR 7.97bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | EUR 1.11bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2021-12-31 | EUR 3.42bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2021-12-31 | EUR 17.40bn | ifrs-full:CurrentAssets |
| Total assets | at 2021-12-31 | EUR 75.09bn | ifrs-full:Assets |
| Current liabilities | at 2021-12-31 | EUR 24.78bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2021-12-31 | EUR 55.35bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2021-12-31 | EUR 17.11bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2021-12-31 | 2,629,243,772 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/217410/000021741022000009/ul-20211231.htm

Filed Mar 9, 2022.
Source: SEC EDGAR, the filing index for accession 0000217410-22-000009. Last ingested by Listed: Nov 3, 2026, 13:07 ET. No prices; not investment advice.